Here are relevant reports on : ai-gi-pathology
-
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Global Forecast to 2028
The global microbiome diagnostics market, valued at US$126 million in 2022, stood at US$146 million in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$300 million by the end of the period. Market growth is driven by the rising incidence of chronic diseases, collaborative efforts between microbiome industry and academic institutes, and growing demand of personalized medicine.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
AI in Networks Market by Offering (Router & Switches, AI Networking Platform, Management Software, Software Defined Networking), Function (Optimization, Cybersecurity, Predictive Maintenance), Technology (Gen AI, ML, NLP) - Global Forecast to 2029
The global AI in Networks market is expected to grow from USD 10.9 billion in 2024 to USD 46.8 billion by 2029, at a compound annual growth rate (CAGR) of 33.8% during the forecast period.The key players NVIDIA Corporation, Cisco Systems, Inc. (US), Telefonaktiebolaget LM Ericsson (Sweden), Hewlett Packard Enterprise Development LP (US), Arista Networks, Inc. (US).
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region - Global Forecast to 2026
The global anatomic pathology market growth is primed to transition from $35.1 billion in 2021 to $49.1 billion by 2026, showcasing a strong CAGR of 7.0%. The growth of this market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
AI in Sports Market by Solutions (Performance Analytics, Player Monitoring, Broadcast Management), Technology (Generative AI and Other AI), and End User (Sports Associations, Sports Teams) - Global Forecast to 2030
The AI in Sports market is projected to reach USD 2.61 billion by 2030 at a compound annual growth rate (CAGR) of 16.7% during the forecast period. The major vendors covered in the AI in Sports market are Cisco (US), IBM (US), Intel (US), Microsoft (US), AWS (US), SAP SE (Germany), Ericsson (Sweden), Oracle (US), Stats Perform (US), Tech Mahindra (India), Sportradar AG (Switzerland), HCL Technologies (India), Extreme Networks (US), Salesforce (US), SAS Institute (US). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the AI in Sports market.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Anatomic Pathology Track and Trace Solutions Market by Product (Software, Hardware (Printer & Labeling Systems), Consumables), Technology (Barcode, RFID), Application (Tissue Cassette, Slide Tracking), End User (Hospital Labs) - Global Forecast to 2023
The global anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4%. The increasing volume of diagnostic tests performed in anatomic pathology laboratories, rising number of legal cases around cancer misdiagnosis, benefits of automated labeling solutions, increasing consolidation among anatomic pathology laboratories, and the growing adoption of automated systems to enhance the efficiency of laboratories are the major factors driving the growth of this market. However, the high cost associated with the implementation of track and trace solutions in anatomic pathology laboratories is expected to restrain the growth of this market during the forecast period. The key players operating in the global anatomic pathology track and trace solutions market are Thermo Fisher Scientific (US), Leica Biosystems (Germany), General Data Healthcare (US), Ventana Medical Systems (US), Agilent Technologies (US), Sunquest Information Systems (US), Zebra Technologies Corporation (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User & Region - Global Forecast to 2025
The global veterinary PoC diagnostics market growth is primed to transition from $1.4 billion in 2019 to $2.4 billion by 2025, showcasing a strong CAGR of 8.9%. Key drivers include the rising prevalence of zoonotic diseases in animals and the need for rapid diagnostics, though high costs of imaging equipment pose a challenge.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Legal AI Software Market by Offering (Legal AI Platforms, Generative AI Agents, Legal Drafting Tools, Report Generation Tools), Application (Ediscovery, Legal Research & Analytics, Contract Drafting & Review, IP Management) - Global Forecast to 2030
The legal AI software market is expected to grow from USD 3.11 billion in 2025 to USD 10.82 billion by the year 2030, at a CAGR of 28.3% during the forecast period. The major players in the legal AI software market include LexisNexis (US), Thomson Reuters (Canada), Sirion (US), Wolters Kluwer (Netherlands), Relativity (US), CS DISCO (US), and Consilio (US), along with SMEs and startups such as Harvey (US), vLex (US), Lawgeex (US), Neota Logic (US), and eBrevia (US).
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Microscopy Market by Product (Optical Microscope: Stereo, Digital; Electron Microscope: SEM, TEM; AFM, STM), Application (Pharma Mfg., Pathology, Drug Discovery, Toxicology), End User (Pharma-Biopharma, F&B, Academia, Semiconductor) - Global Forecasts to 2031
The global microscopy market, valued at US$8.35 billion in 2024, stood at US$8.81 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2031, culminating in a forecasted valuation of US$11.44 billion by the end of the period. The global microscopy market plays a very important and enabling part in the life sciences and research community, and its applications beyond biologic imaging are growing very rapidly in semiconductor device manufacturing.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030
Global digital pathology market valued at $1.30B in 2024, reached $1.46B in 2025, and is projected to grow at a robust 13.5% CAGR, hitting $2.75B by 2030. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Neurovascular Devices Market by Disease Pathology (Cerebral Aneurysm (Embolic coils, Flow Diverters), Ischemic Stroke (Clot Retriever, Aspiration, Snare), Carotid Stenosis (Stent, Embolic Protection), Others), End User (Hospitals) - Global Forecast to 2030
The global neurovascular devices market, valued at US$4.27 billion in 2024, stood at US$4.64 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2024 to 2030, culminating in a forecasted valuation of US$7.22 billion by the end of the period. The market growth is primarily driven by the prevalence of neurovascular diseases, influenced by factors such as aging populations, hypertension, smoking, and sedentary lifestyles.
- Published: November 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
